Skip to content
Home/Companies/Pharma/Karo Pharma (Karo Bio)

Karo Pharma (Karo Bio)

Pharma·Sweden·Exited 1998·Held 2yr
Entry
1996
Hold
2yr
Exit
1998

Who owns Karo Pharma (Karo Bio)?

Karo Pharma (Karo Bio) is a Swedish Pharma company, formerly owned by HealthCap, exited in 1998 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap (early funds) · 1996 · VC

Key facts

HQSweden
SectorPharma
StatusAcquired
Exit Type
IPO
Exit Year
1998

More from HealthCap (early funds)

Other portfolio companies in the same fund.

Affibody AB
Active
BiotechSweden· 2001
Pharmion Corp.
Exited 2003
PharmaUS· 2001
Gyros AB
Exited 2016
MedTechSweden· 2000
to Mesa Laboratories
Cytos Biotechnology AG
Exited 2002
BiotechSwitzerland· 1999
Actelion Holding Ltd
Exited 2017
PharmaSwitzerland· 1997
to Johnson & Johnson
Biotage AB (Pyrosequencing AB)
Exited 2000
BiotechSweden· 1997

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Karo Pharma (Karo Bio)?

Karo Pharma (Karo Bio) was formerly owned by HealthCap, exited in 1998. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue